Glycomantra Inc
Glycomantra Inc. is a biotechnology company based in Aldie, VA, focused on creating innovative therapies to meet critical medical needs in metastatic castration-resistant prostate cancer, NASH liver fibrosis, and type 2 diabetes. With a commitment to glycobiology, the company aims to develop carbohydrate-based therapeutics that address abnormal protein-carbohydrate interactions associated with these diseases.
Central to Glycomantra's research is galectin-3, a protein implicated in cancer progression and metastasis, which the company seeks to target with high-affinity carbohydrate-based drugs. The experienced team at Glycomantra is dedicated to advancing translational research in glycobiology, striving to improve patient outcomes through groundbreaking therapeutic solutions.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.